This bill would reauthorize programs related to America’s bone marrow and cord blood donor registry that manages the inventory and use of stem cells in treating diseases. These programs make up an integrated, nationwide system for transplants of bone marrow and cord blood stem cells. They will expire on September 30, 2015 without this reauthorization.
Cord blood stem cells are taken from adults, and along with transplanted bone marrow have been shown to treat diseases like leukemia, sickle cell anemia, and other genetic disorders.
Both programs would be extended through the 2020 fiscal year, and funded at a level of $23 million for each of those fiscal years.